Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (2159)
AN2 Therapeutics, Inc. (ANTX)
Williams Sarah Joanne — Principal Accounting Officer
Shares
327
Price
$1.06
Total Value
$346.62
Shares Held After
66,848
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
421
Price
$507.09
Total Value
$213.49K
Shares Held After
130
% of Holdings
76.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
132
Price
$506.16
Total Value
$66.81K
Shares Held After
551
% of Holdings
19.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
908
Price
$505.06
Total Value
$458.59K
Shares Held After
683
% of Holdings
57.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
730
Price
$503.99
Total Value
$367.91K
Shares Held After
1,591
% of Holdings
31.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
210
Price
$503.03
Total Value
$105.64K
Shares Held After
2,321
% of Holdings
8.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
379
Price
$501.93
Total Value
$190.23K
Shares Held After
2,531
% of Holdings
13.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
495
Price
$500.96
Total Value
$247.98K
Shares Held After
2,910
% of Holdings
14.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,058
Price
$499.85
Total Value
$528.85K
Shares Held After
3,405
% of Holdings
23.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,371
Price
$498.95
Total Value
$684.07K
Shares Held After
4,463
% of Holdings
23.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,075
Price
$498.01
Total Value
$535.36K
Shares Held After
5,834
% of Holdings
15.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
407
Price
$496.71
Total Value
$202.16K
Shares Held After
6,909
% of Holdings
5.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
555
Price
$495.87
Total Value
$275.21K
Shares Held After
7,316
% of Holdings
7.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
680
Price
$494.75
Total Value
$336.43K
Shares Held After
7,871
% of Holdings
8.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
456
Price
$493.71
Total Value
$225.13K
Shares Held After
8,551
% of Holdings
5.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
340
Price
$492.53
Total Value
$167.46K
Shares Held After
9,007
% of Holdings
3.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
283
Price
$491.68
Total Value
$139.15K
Shares Held After
9,347
% of Holdings
2.9%
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
Francis Richard D — President and CEO
Shares
412,032
Price
$32.36
Total Value
$13.33M
Shares Held After
1,121,382
% of Holdings
26.9%
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
Francis Richard D — President and CEO
Shares
30,903
Price
$32.36
Total Value
$1.00M
Shares Held After
642,099
% of Holdings
4.6%
HARROW, INC. (HROW)
Opaleye Management Inc. — 10% Owner
Shares
1,309
Price
$39.15
Total Value
$51.25K
Shares Held After
63,691
% of Holdings
2.0%
HARROW, INC. (HROW)
Opaleye Management Inc. — 10% Owner
Shares
59,000
Price
$39.15
Total Value
$2.31M
Shares Held After
3,756,000
% of Holdings
1.5%
Ceribell, Inc. (CBLL)
Foehr David — Senior VP, Finance and PAO
Shares
1,157
Price
$17.80
Total Value
$20.59K
Shares Held After
17,550
% of Holdings
6.2%
Ceribell, Inc. (CBLL)
Foehr David — Senior VP, Finance and PAO
Shares
3,403
Price
$17.80
Total Value
$60.57K
Shares Held After
17,550
% of Holdings
16.2%
Ceribell, Inc. (CBLL)
ROBERTSON REBECCA B — Director
Shares
827
Price
$17.80
Total Value
$14.72K
Shares Held After
18,749
% of Holdings
4.2%
Ceribell, Inc. (CBLL)
Chao Xingjuan — Director
Shares
23,554
Price
$17.45
Total Value
$411.02K
Shares Held After
711,164
% of Holdings
3.2%
Ceribell, Inc. (CBLL)
Chao Xingjuan — Director
Shares
1,446
Price
$17.46
Total Value
$25.25K
Shares Held After
711,164
% of Holdings
0.2%
Ceribell, Inc. (CBLL)
Chao Xingjuan — Director
Shares
14,000
Price
$17.45
Total Value
$244.30K
Shares Held After
711,164
% of Holdings
1.9%
LIGAND PHARMACEUTICALS INC (LGND)
Sabba Stephen L — Director
Shares
2,034
Price
$201.50
Total Value
$409.85K
Shares Held After
33,793
% of Holdings
5.7%
LABCORP HOLDINGS INC. (LH)
Schechter Adam H — Director
Shares
8,705
Price
$279.96
Total Value
$2.44M
Shares Held After
80,773
% of Holdings
9.7%
Adaptive Biotechnologies Corp (ADPT)
ROBINS HARLAN S — Chief Scientific Officer
Shares
14,233
Price
$16.52
Total Value
$235.13K
Shares Held After
1,155,291
% of Holdings
1.2%
Xencor Inc (XNCR)
Dahiyat Bassil I — Director
Shares
6,758
Price
$11.90
Total Value
$80.39K
Shares Held After
567,792
% of Holdings
1.2%
Xencor Inc (XNCR)
Eckert Celia — SVP, GENERAL COUNSEL
Shares
1,492
Price
$11.90
Total Value
$17.75K
Shares Held After
81,929
% of Holdings
1.8%
Xencor Inc (XNCR)
Desjarlais John R — SR. VICE PRESIDENT & CSO
Shares
2,663
Price
$11.90
Total Value
$31.68K
Shares Held After
270,451
% of Holdings
1.0%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
359
Price
$321.58
Total Value
$115.45K
Shares Held After
21,860
% of Holdings
1.6%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
722
Price
$320.51
Total Value
$231.41K
Shares Held After
22,219
% of Holdings
3.1%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
282
Price
$318.62
Total Value
$89.85K
Shares Held After
22,941
% of Holdings
1.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
289
Price
$316.55
Total Value
$91.48K
Shares Held After
23,223
% of Holdings
1.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
463
Price
$321.50
Total Value
$148.85K
Shares Held After
23,406
% of Holdings
1.9%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
640
Price
$320.48
Total Value
$205.11K
Shares Held After
23,869
% of Holdings
2.6%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
317
Price
$319.06
Total Value
$101.14K
Shares Held After
24,509
% of Holdings
1.3%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
355
Price
$316.74
Total Value
$112.44K
Shares Held After
24,826
% of Holdings
1.4%
ARTIVION, INC. (AORT)
Holloway Jean F — SVP, General Counsel
Shares
3,843
Price
$37.78
Total Value
$145.17K
Shares Held After
194,057
% of Holdings
1.9%
Airsculpt Technologies, Inc. (AIRS)
Chernett Jorey — 10% Owner
Shares
80,000
Price
$1.71
Total Value
$136.80K
Shares Held After
6,322,611
% of Holdings
1.3%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
6,519
Price
$69.33
Total Value
$451.98K
Shares Held After
767,780
% of Holdings
0.8%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
13,481
Price
$68.85
Total Value
$928.17K
Shares Held After
774,299
% of Holdings
1.7%
ARTIVION, INC. (AORT)
Horton Amy — VP, Chief Accounting Officer
Shares
901
Price
$37.78
Total Value
$34.04K
Shares Held After
139,088
% of Holdings
0.6%
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)
Farmer Michele — Chief Accounting Officer
Shares
2,979
Price
$1.51
Total Value
$4.51K
Shares Held After
305,948
% of Holdings
1.0%
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)
HENRY CHRISTIAN O — President & CEO
Shares
12,497
Price
$1.51
Total Value
$18.92K
Shares Held After
3,581,813
% of Holdings
0.3%
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)
Van Oene Mark — Chief Operating Officer
Shares
6,504
Price
$1.51
Total Value
$9.85K
Shares Held After
2,243,634
% of Holdings
0.3%
Progyny, Inc. (PGNY)
Swartz Allison — EVP, GC
Shares
4,157
Price
$17.40
Total Value
$72.33K
Shares Held After
89,879
% of Holdings
4.4%
Showing 1701–1750 of 2159 transactions (page 35 of 44)